HIV-associated cryptococcal meningitis
Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity
Aberrant Epstein–Barr virus persistence in HIV carriers is characterized by anti-Epstein–Barr virus IgA and high cellular viral loads with restricted transcription
Cognitive dysfunction in HIV encephalitic SCID mice correlates with levels of Interferon-α in the brain
Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C
Depletion of natural killer cells in the colonic lamina propria of viraemic HIV-1-infected individuals
Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers
CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study
Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults
Effect of twice-daily nevirapine on adherence in HIV-1-infected patients: a randomized controlled study
Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey
Risk of HIV infection but not other sexually transmitted diseases is lower among homeless Muslim men in Kolkata
Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm
HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART
Treatment response to ritonavir-boosted tipranavir versus ritonavir-boosted lopinavir in HIV-1 patients with higher lopinavir mutation scores
Increased incidence of cutaneous mycoses after HAART initiation: a benign form of immune reconstitution disease?
Kaposi's sarcoma in HIV-infected patients: when and how should we evaluate bone involvement?
A truvada hypersensitivity reaction simulating abacavir hypersensitivity
Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta viruses
Large lymphadenopathies complicating the abacavir hypersensitivity reaction